The future of pharmacovigilance: A personal view

European Journal of Clinical Pharmacology

Volumn 64, Issue 2, 2008, Pages 173-181

  Edwards, I Ralph ^a  

^a WHO Foundation Collaborating Centre for International Drug Monitoring   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE;

COMORBIDITY; DATA BASE; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG MONITORING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FRANCE; HEALTH CARE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFORMATION TECHNOLOGY; LEGAL LIABILITY; MEDICAL PRACTICE; MEDICATION ERROR; MEDLINE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PHARMACOEPIDEMIOLOGY; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; TERATOGENICITY; UNITED STATES; WORLD HEALTH ORGANIZATION;

DRUG INDUSTRY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOEPIDEMIOLOGY; PRODUCT SURVEILLANCE, POSTMARKETING; RISK MANAGEMENT;

EID: 39149098450     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-007-0435-9     Document Type: Review

References (15)

1. Moore N et al (1985) Adverse drug reaction monitoring: doing it the French way. Lancet 2(8463):1056-1058
2. Royer R (1990) Pharmacovigilance. The French system. Drug Safety 5(Suppl 1):137-140
3. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Jama 279(15):1200-1205
4. Pirmohamed MJS, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329(7456):15-19
5. Medawar C, Hardon A (2004) Medicines out of control? - Antidepressants and the conspiracy of goodwill. Aksant Academic Publishers, Amsterdam, p. 260
6. Radoilska L, Scott D (2005) Trust in the pharmaceutical industry: a philosophical perspective. University of Cambridge, Cambridge
7. Nelson KM, Talbert RL (1996) Drug-related hospital admissions. Pharmacotherapy 16(4):701-707
8. Lindquist M (2003) Seeing and observing in international pharmacovigilance - achievements and prospects in worldwide drug safety. University of Nijmegen, Nijmegen
9. Norén GN, Bate A, Orre R (2005) A hit-miss model for duplicate detection in the WHO drug safety database. ACM, New York
10. Norén GA (2007) Statistical methods for knowledge discovery in adverse drug reaction surveillance, in Department of Mathematics. Stockholm Univeristy, Stockholm, p. 41
11. Bate A (2003) The use of a Bayesian confidence propagation neural network in pharmacovigilance, in Department of Pharmacology and Clinical Neuroscience. Umeå University, Umeå
12. Edwards I (2005) The WHO World Alliance for Patient Safety: a new challenge or an old one neglected? Drug Safety 28(5):379-386
13. Bowdler J (1997) Effective communications in pharmacovigilance. 1 ed. Communications in Pharmacovigilance, Vol. 1. W Lake Ltd, Birmingham, England, p 89
14. Adice International Limited (2007) The Erice manifesto: for global reform of the safety of medicines in patient care. Drug Saf 30(3):187-190
15. Wright A (2002) Dialogue in pharmacovigilance. Communication in pharmacovigilance, ed. W. A. The Uppsala Monitoring Centre, Uppsala